This inventor holds 3 USPTO granted patents. Top assignee: Astrazeneca Ab. Active years: 2006-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Reims Cedex 2, FR (2006 - 2007)
- Reims Cedex, FR (2009)
Company Filing History:
Years Active: 2006-2009
Title: The Innovative Mind of Maryannick Andree Lamorlette
Introduction
Maryannick Andree Lamorlette is a distinguished inventor based in Reims Cedex 2, France. With a remarkable portfolio that includes three patents, Lamorlette has made significant contributions to the field of pharmaceutical sciences. Her work primarily focuses on innovative chemical compounds that serve as valuable pharmaceutical agents.
Latest Patents
Among her latest patents, Lamorlette has developed novel thieno-pyrrole compounds that are advantageous as gonadotropin-releasing hormone antagonists. These groundbreaking compounds, detailed in the patent, are represented by a specific Formula (I) where R, R, R, and R are defined within the specification. She has also created pharmaceutical formulations based on these compounds, setting forth methods for their application in treatment processes, as well as outlined innovative processes for their preparation. Additionally, her patent concerning 6H-thieno[2,3-b]pyrrole derivatives emphasizes their potential role as antagonists in manipulating gonadotropin-releasing hormone (GnRH).
Career Highlights
Maryannick Andree Lamorlette is currently working with AstraZeneca AB, a global leader in biopharmaceuticals. Her dedication to research and development within a prestigious company underscores her commitment to advancing medical therapies that could impact the lives of many. Her patents reflect not only her inventive spirit but also her emphasis on practical applications in the medical field.
Collaborations
Throughout her career, Lamorlette has collaborated with esteemed colleagues, including Kevin Michael Foote and Zbigniew Stanley Matusiak. These partnerships highlight the significance of teamwork in advancing innovative ideas and the collective effort necessary to bring new inventions to fruition.
Conclusion
Maryannick Andree Lamorlette's innovative contributions to pharmaceutical chemistry demonstrate her position as a leading inventor in the field. Her patents reveal a commitment to developing cutting-edge solutions to enhance medical treatments, solidifying her reputation as a trailblazer among inventors. As she continues her work at AstraZeneca AB, the impact of her inventions and collaborations is poised to resonate widely in the medical community, shaping future advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile